However, unlike these previous studies, the subgroup analysis of diabetic subjects in our study revealed that though the use of metformin was associated with favorable survival ( Table 3 ), it failed to reach statistical significance.
← all excerpts
Impact of Metabolic Syndrome Diagnosis and Its Treatment on Survival of Colorectal Cancer Patients.
1
—
—